Literature DB >> 23532836

Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model.

Mehrnaz Gharaee-Kermani1, Jose A Rodriguez-Nieves, Rohit Mehra, Chad A Vezina, Aruna V Sarma, Jill A Macoska.   

Abstract

BACKGROUND: Progressive aging- and inflammation-associated fibrosis effectively remodels the extracellular matrix (ECM) to increase prostate tissue stiffness and reduce urethral flexibility, resulting in urinary flow obstruction and lower urinary tract symptoms (LUTS). In the current study, we sought to test whether senescence-accelerated mouse prone (SAMP)6 mice, which were reported to develop prostatic fibrosis, would also develop LUTS, and whether these symptoms would be exacerbated by diet-induced obesity and concurrent Type 2 Diabetes Mellitus (T2DM).
METHODS: To accomplish this, SAMP6 and AKR/J background strain mice were fed regular mouse chow, low fat diet chow, or high fat diet chow for 8 months, then subjected to glucose tolerance tests, assessed for plasma insulin levels, evaluated for urinary voiding function, and assessed for lower urinary tract fibrosis.
RESULTS: The results of these studies show that SAMP6 mice and AKR/J background strain mice develop diet-induced obesity and T2DM concurrent with urinary voiding dysfunction. Moreover, urinary voiding dysfunction was more severe in SAMP6 than AKR/J mice and was associated with pronounced prostatic and urethral tissue fibrosis.
CONCLUSIONS: Taken together, these studies suggest that obesity, T2DM, lower urinary tract fibrosis, and urinary voiding dysfunction are inextricably and biologically linked.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23532836      PMCID: PMC5512573          DOI: 10.1002/pros.22662

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  45 in total

Review 1.  Benign prostatic hyperplasia: antecedents and natural history.

Authors:  H A Guess
Journal:  Epidemiol Rev       Date:  1992       Impact factor: 6.222

2.  Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.

Authors:  G Theyer; G Kramer; I Assmann; E Sherwood; W Preinfalk; M Marberger; O Zechner; G E Steiner
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

3.  Correlates of urinary symptom scores in men.

Authors:  B E Klein; R Klein; K E Lee; R C Bruskewitz
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

Review 4.  Molecular targets in pulmonary fibrosis: the myofibroblast in focus.

Authors:  Chris J Scotton; Rachel C Chambers
Journal:  Chest       Date:  2007-10       Impact factor: 9.410

5.  CXCL12 activates a robust transcriptional response in human prostate epithelial cells.

Authors:  Lesa A Begley; James W MacDonald; Mark L Day; Jill A Macoska
Journal:  J Biol Chem       Date:  2007-07-12       Impact factor: 5.157

Review 6.  Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.

Authors:  J Kellogg Parsons; Aruna V Sarma; Kevin McVary; John T Wei
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

Review 7.  Pathobiology of the senescence-accelerated mouse (SAM).

Authors:  T Takeda; T Matsushita; M Kurozumi; K Takemura; K Higuchi; M Hosokawa
Journal:  Exp Gerontol       Date:  1997 Jan-Apr       Impact factor: 4.032

8.  Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.

Authors:  Paulo Tadeu Dib; Flavio Trigo-Rocha; Cristiano Mendes Gomes; Miguel Srougi
Journal:  Urol Int       Date:  2008-06-27       Impact factor: 2.089

9.  The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy.

Authors:  L A Begley; S Kasina; J MacDonald; J A Macoska
Journal:  Cytokine       Date:  2008-06-24       Impact factor: 3.861

10.  Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.

Authors:  J Kellogg Parsons
Journal:  Curr Bladder Dysfunct Rep       Date:  2010-09-07
View more
  37 in total

1.  Influence of animal husbandry practices on void spot assay outcomes in C57BL/6J male mice.

Authors:  Kimberly P Keil; Lisa L Abler; Helene M Altmann; Wade Bushman; Paul C Marker; Lingjun Li; William A Ricke; Dale E Bjorling; Chad M Vezina
Journal:  Neurourol Urodyn       Date:  2014-11-12       Impact factor: 2.696

2.  Evaluation of voiding assays in mice: impact of genetic strains and sex.

Authors:  Dale E Bjorling; Zunyi Wang; Chad M Vezina; William A Ricke; Kimberly P Keil; Weiqun Yu; Lianyu Guo; Mark L Zeidel; Warren G Hill
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-22

Review 3.  Estrogens and Male Lower Urinary Tract Dysfunction.

Authors:  Jalissa L Wynder; Tristan M Nicholson; Donald B DeFranco; William A Ricke
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

4.  Fluorescence of Picrosirius Red Multiplexed With Immunohistochemistry for the Quantitative Assessment of Collagen in Tissue Sections.

Authors:  Kyle A Wegner; Adib Keikhosravi; Kevin W Eliceiri; Chad M Vezina
Journal:  J Histochem Cytochem       Date:  2017-07-10       Impact factor: 2.479

5.  Histotripsy of the Prostate in a Canine Model: Characterization of Post-Therapy Inflammation and Fibrosis.

Authors:  Sarah E Darnell; Timothy L Hall; Scott A Tomlins; Xu Cheng; Kimberly A Ives; William W Roberts
Journal:  J Endourol       Date:  2015-02-18       Impact factor: 2.942

6.  Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the MTOPS Study.

Authors:  Jill A Macoska; Kristen S Uchtmann; Glen E Leverson; Kevin T McVary; William A Ricke
Journal:  J Urol       Date:  2019-06-12       Impact factor: 7.450

7.  Inhibition of the CXCL12/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo.

Authors:  Jill A Macoska; Zunyi Wang; Johanna Virta; Nicholas Zacharias; Dale E Bjorling
Journal:  Prostate       Date:  2019-02-27       Impact factor: 4.104

8.  Evaluating the voiding spot assay in mice: a simple method with complex environmental interactions.

Authors:  Huan Chen; Lanlan Zhang; Warren G Hill; Weiqun Yu
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-23

Review 9.  Void spot assay: recommendations on the use of a simple micturition assay for mice.

Authors:  Warren G Hill; Mark L Zeidel; Dale E Bjorling; Chad M Vezina
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-29

10.  Complex cellular composition of solitary fibrous tumor of the prostate.

Authors:  Mehrnaz Gharaee-Kermani; Rohit Mehra; Dan R Robinson; John T Wei; Jill A Macoska
Journal:  Am J Pathol       Date:  2014-01-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.